With another earnings season upon us, the Fool's health-care team is busy making sure investors know what to expect from their favorite companies this quarter, while also maintaining a focus on the long term.
In this video segment, health-care bureau chief Brenton Flynn discusses the upcoming earnings report from Abbott Labs (ABT +0.45%) and AbbVie (ABBV +0.52%). As Brenton notes, this is the last time that investors will see combined results from these now-separate companies.
